Gajraj, Elangovan <br/><br/>
Rituximab for follicular non-Hodgkin lymphoma.  [electronic resource] 

 -  The Lancet. Oncology  Apr 2008 
 - 320-1 p.  digital 
<br/><br/> Publication Type: News 
<br/><br/><label>ISSN: </label>1474-5488 
<br/><br/><label>Standard No.: </label>10.1016/S1470-2045(08)70036-6  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antibodies, Monoclonal--therapeutic use<br/>Antibodies, Monoclonal, Murine-Derived<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Clinical Trials as Topic<br/>Evaluation Studies as Topic<br/>Female<br/>Humans<br/>Lymphoma, Follicular--diagnosis<br/>Male<br/>Prognosis<br/>Remission Induction<br/>Rituximab<br/>Sensitivity and Specificity<br/>Severity of Illness Index<br/>Societies, Medical<br/>Survival Analysis<br/>Treatment Outcome<br/>United Kingdom